The Neuropharmacology of Tomorrow
The Vantage Point. A weekly take on psychedelic drug development: pipeline, mechanism, and regulatory intelligence.
Sign up with Email
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Already have an account?
Log In
By signing up to create an account I accept Compaany's
Terms of Use and Privacy Policy
Email Sign UP
Weekly coverage of psychedelic therapeutics: pipeline, mechanism, and regulatory intelligence.
Already have an account?
Log In
or
Sign up with Google
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By signing up to create an account I accept Compaany's
Terms of Use and Privacy Policy
Cascades Analytics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Need an account?
Sign up
About
ANALYSIS
Contact
JOIN
FRI 13 MAR 2026
Source
CURRENT
RAPIDS
Gauge
Cascades Analytics with Chris Witowski (Psilera)
Cascades Analytics with Chris Witowski (Psilera)
10.14.25
We interviewed live Psilera's CEO & Co-Founder, Chris Witowski, PhD, to discuss next-generation psychedelics and their emerging indications in FTD and Anxiety Disorders.
SHARE:
LinkedIn
X
Email
Copy Link